Effects of Isolated LBBB on Maximal Functional Capacity
Launched by FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL CLÍNICO DE VALENCIA · Dec 7, 2022
Trial Information
Current as of February 05, 2025
Completed
Keywords
ClinConnect Summary
Left bundle branch block (LBBB) has been commonly associated with adverse cardiovascular (CV) events, but the effect of an isolated LBBB on maximal functional capacity is not well characterized.
The main objective of the study is to evaluate the effect of LBBB on maximum functional capacity (objectively evaluated by the maximum oxygen consumption -VO2max- at peak exercise in a cardiopulmonary stress test -CPET-) in subjects with LBBB without known cardiovascular disease and compare these data with controls without LBBB.
This is a prospective study that will be carried out in a single cent...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult \>18 years old
- • ECG criteria of left bundle branch block (for controls without left bundle branch block )
- • Provide informed consent
- Exclusion Criteria:
- • Inability to perform a maximal baseline exercise test;
- • Structural heart disease, valve heart disease or diastolic dysfunction estimated by two-dimensional echocardiography;
- • Previous ischemic heart disease, heart failure, myocardiopathy or myocarditis
- • Effort angina during cardiopulmonary exercise testing (CPET);
- • Any moderate pulmonary disease;
- • Anaemia
- • Left ventricular ejection fraction \< 55%.
Trial Officials
Patricia Palau, MD, PhD
Principal Investigator
INCLIVA
About Fundación Para La Investigación Del Hospital Clínico De Valencia
The Fundación para la Investigación del Hospital Clínico de Valencia is a prominent research organization dedicated to advancing medical knowledge and improving patient care through clinical trials and biomedical research. Based in Valencia, Spain, the foundation collaborates closely with the Hospital Clínico Universitario de Valencia to facilitate innovative studies across various medical disciplines. Its mission is to promote scientific excellence and foster collaboration among healthcare professionals, researchers, and institutions, ultimately aiming to translate research findings into effective therapies and interventions for the benefit of patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, , Spain
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials